AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01012-06v1
51/3/1064    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eksi, S.
Right arrow Articles by Williamson, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eksi, S.
Right arrow Articles by Williamson, K. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2007, p. 1064-1070, Vol. 51, No. 3
0066-4804/07/$08.00+0     doi:10.1128/AAC.01012-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Inhibition of Plasmodium falciparum Oocyst Production by Membrane-Permeant Cysteine Protease Inhibitor E64d{triangledown}

S. Eksi,1 B. Czesny,1 G.-J. van Gemert,2 R. W. Sauerwein,2 W. Eling,2 and K. C. Williamson1*

Department of Biology, Loyola University Chicago, Chicago, Illinois,1 Department of Medical Microbiology, University of Nijmegen, Nijmegen, The Netherlands2

Received 13 August 2006/ Returned for modification 24 September 2006/ Accepted 6 December 2006

During asexual intraerythrocytic growth, Plasmodium falciparum utilizes hemoglobin obtained from the host red blood cell (RBC) as a nutrient source. Papain-like cysteine proteases, falcipains 2 and 3, have been reported to be involved in hemoglobin digestion and are targets of current antimalarial drug development efforts. However, their expression during gametocytogenesis, which is required for malaria parasite transmission, has not been studied. Many of the available antimalarials do not inhibit development of sexual stage parasites, and therefore, the persistence of gametocytes after drug treatment allows continued transmission of the disease. In the work reported here, incubation of stage V gametocytes with membrane-permeant cysteine protease inhibitor E64d significantly inhibited oocyst production (80 to 100%). The same conditions inhibited processing of gametocyte-surface antigen Pfs230 during gametogenesis but did not alter the morphology of the food vacuole in gametocytes, inhibit emergence, or block male exflagellation. E64d reduced the level of oocyst production more effectively than that reported previously for falcipain 1-knockout parasites, suggesting that falcipains 2 and 3 may also be involved in malaria parasite transmission. However, in this study only falcipain 3 and not falcipain 2 was found to be expressed in stage V gametocytes. Interestingly, during gametocytogenesis falcipain 3 was transported into the red blood cell and by stage V was localized in vesicles along the RBC surface, consistent with a role during gamete emergence. The ability of a membrane-permeant cysteine protease inhibitor to significantly reduce malaria parasite transmission suggests that future drug design should include evaluation of gametogenesis and sporogonic development.


* Corresponding author. Mailing address: Department of Biology, Quinlan Life Sciences Building, Rm 317, 6525 N. Sheridan Rd., Loyola University Chicago, Chicago, IL 60626. Phone: (773) 508-3631. Fax: (773) 508-3646. E-mail: kwilli4{at}luc.edu.

{triangledown} Published ahead of print on 18 December 2006.


Antimicrobial Agents and Chemotherapy, March 2007, p. 1064-1070, Vol. 51, No. 3
0066-4804/07/$08.00+0     doi:10.1128/AAC.01012-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.